• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

NIHR Oxford Health Biomedical Research Centre

MENUMENU
  • About
    • About
    • Management and core team
    • Our partners
    • Timeline of our key achievements
    • Core facilities
    • Work with us
    • Contact
  • Departments
    • NIHR Oxford Cognitive Health Clinical Research Facility
    • Brain Health Centre
    • Oxford Precision Psychiatry Lab (OxPPL)
    • Oxford Dementia and Ageing Research (OxDARE)
    • Treatment Resistant Depression Clinic
    • Experimental Medicine and Industry Partnership (EMIP)
  • Research Themes
    • Better Sleep
    • Brain Technologies
    • Data Science
    • Dementia
    • Depression Therapeutics
    • Flourishing & Wellbeing
    • Mental Health in Development
    • Molecular Targets
    • Pain
    • Preventing Multiple Morbidities
    • Psychological Treatments
  • COVID-19 Research
    • Overview
    • News
    • COVID-19 & clinical management of mental health issues
  • News & Events
    • News
    • Training and Events
    • Psychiatry Department Seminars
  • Patients & Public
    • About Patient and Public Involvement
    • Shape our research
    • Take part in our research
    • Resources for researchers
    • Resources for the public
    • Patient and Public Involvement Strategy
    • Young people’s involvement
  • Training Hub
You are here: Home / News / COVID-19 and mental health – evidence-based guidance

COVID-19 and mental health – evidence-based guidance

10th June 2021

Researchers from the Oxford Precision Psychiatry Lab responded to COVID-19 by creating vital evidence-based guidance for patients and clinicians managing mental health conditions during the pandemic.

Frequently updated, this guidance summarises the best available clinical guidelines about key COVID-19 questions that are faced by frontline mental health professionals every day.

Designed for busy clinicians and organised around specific clinical questions the guidance is derived from existing guidelines in the English language (covering the UK, USA, Canada, Australia, New Zealand and Singapore).

The guidance has enjoyed widespread acclaim, covers 12 topics and has been adapted for use internationally with versions created for Bulgaria, China, France, Italy, Japan, and Turkey.

The evidence-based guidance now covers the following topics:

Benzodiazepines and Z-drugs (zopiclone and zolpidem)
Clozapine treatment
Digital technologies and telepsychiatry
Domestic violence and abuse

End of life care
Inpatient wards
Lithium treatment
Long-acting injectable (LAI) antipsychotics
Pregnancy and the perinatal period
Suicide and self-harm
Vaccine prioritisation and mental health
Vaccine uptake and vaccine hesitancy

The guidance has prompted discussions and publications on key areas relating to COVID-19 and mental health some of which are listed below. Visit our out media and publications page for a more complete list.

  • Covid-19 and mental health: a transformational opportunity to apply an evidence-based approach to clinical practice and research 
  • COVID-19 and Telepsychiatry: Development of Evidence-Based Guidance for Clinicians 
  • COVID-19, mental health, and ethnic minorities 
  • COVID-19 vaccination prioritisation and mental health: 
  • COVID-19 vaccine hesitancy and mental health

Filed Under: News

Primary Sidebar

News Categories

  • News
    • Clinical Research Facility
    • COVID-19 research
      • Children, young people and family mental health
      • COVID-19 and psychiatric diagnosis
      • Online therapies and resources for clinicians
      • Patient and Public Involvement in the pandemic
      • PHOSP COVID
      • Vaccination and vaccine hesitancy
    • Research Themes
      • Better Sleep
      • Brain Technologies
      • Data Science
      • Dementia
      • Depression Therapeutics
      • Flourishing & Wellbeing
      • Mental Health in Development
      • Molecular Targets
      • Pain
      • Preventing Multiple Morbidities
      • Psychological Treatments
    • Training and Development
Tweets by OxHealthBRC
Follow @OxHealthBRC

Footer

Follow us

  • LinkedIn
  • Twitter
  • YouTube

Improving brain health: the future in mind

The National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) is a partnership between Oxford Health NHS Foundation Trust and the University of Oxford.  We are part of the Oxford Academic Health Partners.
Oxford Academic Health Partners
  • Sitemap
  • Accessibility
  • Disclaimer
  • Cookies
  • Contact

© 2023 NIHR Oxford Health Biomedical Research Centre · Log in

Cookies

This site uses cookies: See our privacy policy